Mahathir Bayena

New Hope (ASX:NHC) reported a net profit after tax of $161 million for the 2026 financial year.

Kaiko has extended its Series B funding round to US$110 million after S&P Global led a new investment.

Abbott (NYSE:ABT) agreed to pay $385 million on September 14, 2026, to resolve government and civil claims connected to its 2022 powdered infant formula recall.

Oracle (NYSE:ORCL) disclosed that it is expanding its 2026 Restructuring Plan by approximately $700 million, bringing the estimated total cost of the program to roughly $2.8 billion.

Boeing (NYSE:BA) and American Airlines (NASDAQ:AAL) completed the first 737 MAX landing gear exchange on September 14, 2026.

Phio Pharmaceuticals (NASDAQ:PHIO) submitted a meeting request and comprehensive briefing package to the U.S. Food and Drug Administration to support the next phase of development for its INTASYL siRNA candidate PH-762.

Telix (NASDAQ:TLX) received U.S. Food and Drug Administration approval for Pixclara, or floretyrosine F 18, as a PET imaging drug for evaluating glioma.

Digital Realty (NYSE:DLR) formed a strategic joint venture with Rönesans Infrastructure to develop and operate next-generation, carrier-neutral data centers across Türkiye.

AstraZeneca (NASDAQ:AZN) reported updated Phase III ADAURA results showing TAGRISSO reduced the risk of death by 48% versus placebo after eight years in the overall Stage IB-IIIA EGFR-mutated NSCLC population.

Rumble Resources (ASX:RTR) announced scheduled exploration programmes across three of its Western Australian gold and base metal projects.